New England Private Wealth Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,181
Closed -$199K 120
2019
Q3
$199K Buy
13,181
+129
+1% +$2.07K 0.05% 160
2019
Q2
$220K Buy
13,052
+116
+0.9% +$1.91K 0.05% 146
2019
Q1
$221K Buy
12,936
+100
+0.8% +$1.73K 0.06% 141
2018
Q4
$194K Buy
12,836
+144
+1% +$2.54K 0.06% 135
2018
Q3
$260K Buy
12,692
+98
+0.8% +$1.95K 0.07% 119
2018
Q2
$237K Buy
12,594
+100
+0.8% +$1.88K 0.07% 127
2018
Q1
$240K Buy
12,494
+99
+0.8% +$1.98K 0.07% 123
2017
Q4
$244K Buy
12,395
+104
+0.8% +$2.08K 0.07% 122
2017
Q3
$264K Buy
12,291
+89
+0.7% +$1.89K 0.08% 113
2017
Q2
$255K Buy
+12,202
New +$247K 0.08% 115
2017
Q1
Sell
-12,035
Closed -$204K 138
2016
Q4
$204K Buy
12,035
+100
+0.8% +$1.76K 0.07% 115
2016
Q3
$224K Hold
11,935
0.08% 111
2016
Q2
$205K Buy
11,935
+144
+1% +$2.66K 0.08% 113
2016
Q1
$212K Buy
11,791
+196
+2% +$3.56K 0.09% 107
2015
Q4
$274K Buy
+11,595
New +$288K 0.11% 91
2015
Q1
Sell
-11,053
Closed -$275K 112
2014
Q4
$275K Buy
11,053
+123
+1% +$2.95K 0.11% 81
2014
Q3
$241K Buy
10,930
+133
+1% +$2.89K 0.1% 86
2014
Q2
$225K Buy
10,797
+132
+1% +$2.77K 0.09% 96
2014
Q1
$232K Sell
10,665
-6,162
-37% -$137K 0.1% 87
2013
Q4
$344K Buy
+16,827
New +$326K 0.16% 66

Other funds holding HQL

New England Private Wealth Advisors's HQL Position: Q4 2019 in Review

New England Private Wealth Advisors sold out of abrdn Life Sciences Investors (HQL) in Q4 2019, closing a stake of 13,181 shares — an estimated $199K sold.

New England Private Wealth Advisors first reported a position in HQL in Q4 2013 and held it in 20 quarters. The position peaked at $344K in Q4 2013. 69 funds tracked by Wall St. Rank hold HQL as of Q4 2019.

  • New England Private Wealth Advisors reported no remaining abrdn Life Sciences Investors position as of Q4 2019 after selling out during the quarter.
  • New England Private Wealth Advisors sold 13,181 abrdn Life Sciences Investors shares in Q4 2019, an estimated $199K.
  • New England Private Wealth Advisors first reported a position in abrdn Life Sciences Investors in Q4 2013 and held it in 20 quarters.
  • New England Private Wealth Advisors's abrdn Life Sciences Investors position peaked at $344K in Q4 2013.
  • 69 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2019.

Based on New England Private Wealth Advisors's 13F filing for Q4 2019, filed 11 Feb 2020.